01 5Bayer Inc.
01 52485143
01 5Riociguat
01 4Tablet
02 1Tablets
01 52023-04-25
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Brand Name : ADEMPAS
Patent Number : 2485143
Filing Date : 2003-04-25
Strength per Unit : 0.5 mg
Dosage Form : Tablets
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Brand Name : ADEMPAS
Patent Number : 2485143
Filing Date : 2003-04-25
Strength per Unit : 1 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Brand Name : ADEMPAS
Patent Number : 2485143
Filing Date : 2003-04-25
Strength per Unit : 1.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Brand Name : ADEMPAS
Patent Number : 2485143
Filing Date : 2003-04-25
Strength per Unit : 2 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
Brand Name : ADEMPAS
Patent Number : 2485143
Filing Date : 2003-04-25
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-25
Date Granted : 2011-04-19
LOOKING FOR A SUPPLIER?
Market Place
